Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network

Mantle cell lymphoma (MCL) is still considered incurable and the course of the disease is highly variable. Established risk factors include the Mantle Cell Lymphoma International Prognostic Index (MIPI) and the quantification of the proliferation rate of the tumour cells, e.g. by Ki-67 immunohistoch...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Br J Haematol
Egile Nagusiak: Rauert-Wunderlich, Hilka, Mottok, Anja, Scott, David W., Rimsza, Lisa M., Ott, German, Klapper, Wolfram, Unterhalt, Michael, Kluin-Nelemans, Hanneke C., Hermine, Olivier, Hartmann, Sylvia, Thorns, Christoph, Rymkiewicz, Grzegorz, Holte, Harald, Dreyling, Martin, Hoster, Eva, Rosenwald, Andreas
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6361690/
https://ncbi.nlm.nih.gov/pubmed/30095158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.15519
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak